NIH scientists find treatment for rare genetic skin disorder
The scientists identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and found a potential treatment. The disorder causes severe skin lesions and poor wound healing and leads to deep scarring of all layers of the skin and muscles.
Collaboration and teamwork ensure that our genomic advances improve health for all humans.
FOR GRANT SEEKERS
To accelerate genomics research, we support scientists at public and private institutions around the world.
FOR HEALTH PROFESSIONALS
Expand your genomics knowledge with resources focused on patient care.
Spark scientific curiosity and engage a diverse community of learners.
The more you know, the better decisions you can make about your health.
About the National Human Genome Research Institute
At NHGRI, we are focused on advances in genomics research. Building on our leadership role in the initial sequencing of the human genome, we collaborate with the world's scientific and medical communities to enhance genomic technologies that accelerate breakthroughs and improve lives. By empowering and expanding the field of genomics, we can benefit all of humankind.